Bharat Biotech finds Covaxin 81% efficient in Phase 3 trials

Bharat Biotech's vaccine, whose emergency use approval before finishing final stage testing had triggered a row, has shown an 81 per cent efficacy in preventing symptomatic COVID-19 in an interim......

Bharat Biotech's Krishna Ella wins Covaxin fight

'He came back from the US only to work for his country.''He has invested his fortunes to build this company and is married to his work.''Rarely does one see such commitment.'Sohini Das reported.......

Covaxin phase 3 trial data to be published in July: Bharat Biotech

Hyderabad-based vaccine manufacturer Bharat Biotech, which is carrying out its phase 3 trial will publish the data in July following that the company will be applying for the full licensure of......

Bharat Biotech cuts vaccine price for states to Rs 400/dose

Bharat Biotech on Thursday announced a cut in the price of its COVID-19 vaccine 'Covaxin' it plans to sell to the states to Rs 400 per dose from the earlier Rs 600. IMAGE: A healthcare worker......

IOA want India's Olympic-bound athletes vaccinated

'Since there are very few months left for the Games and the safety of the participants are utmost important so to ensure all of them are vaccinated for COVID-19 prior to travel to Tokyo.' IMAGE:......